Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYPHY: YPT-01 for CF with Pseudomonas
NCT04684641Phase 2Completed
- Sponsor
- Yale University
- Start
- Mar 2021
- Primary completion
- May 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of OMKO1 in Pseudomonas aeruginosa infection, sponsored by Yale University. Started Mar 2021; status: completed.
02
Drugs
OMKO1
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT04684641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684641.